#151 Cardiorenal Considerations: 5 Pearls Segment

Published: May 13, 2024, 5 a.m.

  • Urinalysis in a patient with AKI from purely cardiorenal syndrome? (~02:05)
  • What is bioavailability, duration of action, and outcomes with furosemide, torsemide, and bumetanide? (~08:47)
  • How can spot urine sodium measurements be used to assess diuretic response? (~18:08)
  • What are the differences between thiazides (PO Metolazone vs. IV Chlorothiazide) and acetazolamide augment diuresis? (~27:35)
  • Spaced Repetition: RAAS inhibitors or SGLT2 inhibitors as GMDT in CKD? (~35:08)


Sponsor:\xa0Freed\xa0is an AI scribe that listens and writes your note in < 30 seconds. Freed\xa0learns your style\xa0over time and is HIPAA compliant!\xa0

Use the code\xa0CORE50\xa0to get 50% off your first month with\xa0Freed

Get\xa0CME-MOC credit\xa0with ACP!

Tags: nephrology, cardiology, primary care, CoreIM, IMcore, nurse practitioner, physician assistant, hospital medicine, pharmacy, diuretic resistance



Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy